Prof Richard Kitney, Co-Director
Dick has been working at the forefront of synthetic biology and has been pivotal in shaping its development in the UK from the outset of UK investment in the technology around 2002-3. He has championed synthetic biology to the public, industry, governments and learned societies, is pre-eminent and globally recognised as pioneering in the field. Dick co-directs, with Professor Paul Freemont, the UK’s first R&D centre for synthetic biology R&D and innovation (CSynBI), the Synthetic Biology Hub at Imperial College London and SynbiCITE.
Prof Paul Freemont, Co-Director
Paul has been working at the forefront of international synthetic biology developments since 2002. He played a key role with Dick Kitney in developing the UK strategy for synthetic biology research, innovation and training and was a co-author of the British Government’s UK Synthetic Biology Roadmap. He was a technical expert at the United Nations Convention for Biological Diversity and Biological Weapons Convention and is a working group member of the US NIST synthetic biology standards consortium.
Dr Geoffrey Baldwin
Geoff is a Reader in Biochemistry at Imperial College London. He has spent his career at the interface of the physical and life sciences, having done an undergraduate degree in Chemistry, he then moved into biochemistry for his PhD working on DNA-protein interactions. He has an active programme of research in DNA assembly, part characterisation and in vivo approaches to directed evolution for the creation of new bioparts.
Dr Tom Ellis
Tom is a senior lecturer leading research in synthetic biology and synthetic genome engineering. He has track record in synthetic biology, being author of over 20 publications in synthetic biology. He is leader of the UK-funded project to build a synthetic yeast chromosome for the international synthetic yeast project (Sc2.0).
Dr Guy-Bart Stan
Guy-Bart is a Reader in Engineering Design for Synthetic Biology and the head of the 'Control Engineering Synthetic Biology' group at Imperial College London. Dr Stan's research explores the modelling, analysis and design of biological systems and the development of engineering methods to facilitate the creation and control of living cells.
Dr Stephen Chambers
Dr Stephen Chambers is CEO at SynbiCITE, the Innovation and Knowledge Centre for Synthetic Biology. He has extensive entrepreneurial experience with start-ups, and was a founding scientist at Vertex Pharmaceuticals and a co-founder of Abpro. Dr Chambers is also the lead teaching faculty for the Lean LaunchPad for Synthetic Biology at Imperial College London.